Shire’s von Willebrand disease therapy Veyvondi approved in EUThe European Commission has approved Shire’s Veyvondi for treatment of the bleeding disorder von Willebrand disease (VWD). VWD Share XShire’s von Willebrand disease therapy Veyvondi approved in EUhttps://pharmaphorum.com/news/shires-von-willebrand-disease-therapy-veyvondi-approved-in-eu/
